About Us

Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

A Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Social Media

Bluesky • Facebook • Instagram • LinkedIn • YouTube

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology
My Watchlist
Indicators
Industrial Laser Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

By: via GlobeNewswire
  • Expanded microbiology lab and analytical chemistry capabilities position Ritedose for accelerated growth.
  • $17+ million investment fuels innovation and scale in drug development.

COLUMBIA, S.C., Sept. 24, 2025 (GLOBE NEWSWIRE) -- The Ritedose Corporation is investing more than $17 million to further its in-house cGMP laboratory capabilities by expanding its analytical chemistry and microbiology laboratories.

The additional 10,000 square footage of lab space and advanced analytical capabilities create a more efficient environment with improved adjacencies that streamline workflows and maximize productivity, enabling Ritedose to meet its growth capacity of 2.6 billion doses per year.

“By expanding our cGMP laboratory space, we’re not just meeting our current needs, we’re preparing Ritedose for the future of pharmaceutical development,” said Ritedose CEO Jody Chastain. “These investments give us the capacity, flexibility and advanced capabilities to support next-generation therapies, strengthen our regulatory leadership, and ensure we can deliver life-changing treatments to patients with even greater speed and reliability.”

The two new lab spaces will triple Ritedose’s current lab footprint, streamlining operations, enabling the company to manage all laboratory functions in-house, and providing turnkey solutions for customers. The enhanced facilities will also position Ritedose as a fully qualified resource for analytical services within the broader life sciences community.

  • Phase I: a state-of-the-art, 10,000-square-foot analytical chemistry laboratory, housed in the newly-opened distribution and logistics facility located at Ritedose Performance Park.
  • The company’s existing analytical laboratory combines office and lab functions in a single space; the new facility will create a clear separation between wet lab operations and office areas, enhancing efficiency and workflow.
  • Phase II: converting the current analytical chemistry lab space (located in Ritedose’s main building) into a 6,000 square foot expansion of the microbiology lab services.
  • Construction of both phases is scheduled for completion in spring 2026.

The expansion strengthens Ritedose's highly skilled, in-house expertise in method development, validation, stability studies and regulatory compliance. The lab is designed to support a full spectrum of analytical testing, from raw material qualification to finished product release and enables delivery of a broad range of analytical services such as extractables and leachables, nitrosamine detection, elemental analysis and comprehensive drug product de-formulation.

Further, Ritedose will build on its reputation for excellence in cGMP analytical services by supporting complex CMC programs, bioequivalence studies and regulatory submissions, while ensuring that every result is generated in accordance with FDA and ICH guidelines.

The expansion of the laboratory space marks the latest step in Ritedose’s ongoing growth strategy. In recent months, the company has opened a state-of-the-art logistics and distribution facility, added a seventh Syntegon packaging line that doubled capacity for individually wrapped vial medications and increased its sterile BFS production capacity by 180-million-unit doses to support ophthalmic and respiratory therapies.

About The Ritedose Corporation

Ritedose is the largest sterile contract development manufacturing organization (CDMO) in the US specializing in sterile Blow Fill Seal (BFS) technology that ensures sterile, consistent, and safe unit dose delivery. The company’s process guides the development of molecules from clinical trials to commercialization of branded and generic inhalation and ophthalmic medications. With a focus on quality, innovation, and customer satisfaction, Ritedose partners with leading pharmaceutical companies to deliver safe, effective, and reliable medications that improve patient outcomes. Ritedose: Passion and Precision with a Purpose. For more information visit Ritedose.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c1cb5d6f-cf84-4654-83d2-24599a0b7e79


Media Contact:
Alex Keown
630-346-5141
akeown@inspire-agency.com
On Behalf of Ritedose

Primary Logo

More News

View More
Hershey vs. Mondelez: Which Stock Wins Chocolate Season?
Via MarketBeat
Topics Economy
Tickers HSY MDLZ PEP
Thor Industries Tracking for New Highs in 2026
Via MarketBeat
Topics Economy
Tickers THO
Cintas Stock Sends a Clear Buy Signal as Momentum Builds
Via MarketBeat
Topics Government
Tickers CTAS
It's a Good Time to Build a Position in KB Home
Via MarketBeat
Tickers KBH
Micron’s Stock Price Rally Is Not Over: MU $190 Is Coming Soon
Via MarketBeat
Topics Artificial Intelligence
Tickers AMD AMZN MSFT MU NVDA ORCL
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.